ACURX PHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.17 USD | -0.91% |
|
+6.37% | -43.34% |
| Apr. 04 | Top Premarket Gainers | MT |
| Mar. 19 | H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating | MT |
Chart calendar Acurx Pharmaceuticals, Inc.
3ce4983c1a9ac8bb95.sc9udopKdPyddCSHYdBiCgZYjB0Z_bHyYydnukGVB3M.-5YAHP8CK7P-IEfCA-Q0aUcv4VFVk9rDK3IEwhDcMSrkoAEupyIZns5FUw~21a404973865c3c6a89a147aa0797179
Upcoming events on Acurx Pharmaceuticals, Inc.
Past events on Acurx Pharmaceuticals, Inc.
| Today 02:30 am | European Society of Clinical Microbiology and Infectious Diseases Congress - Kevin Garey |
| 2024-04-28 06:00 am | European Society of Clinical Microbiology and Infectious Diseases Congress - Poster #P2327 |
| 2024-04-08 02:30 pm | LD Micro Invitational Conference |
| 2024-03-18 08:00 am | Q4 2023 Earnings Call |
| 2024-03-18 07:01 am | Q4 2023 Earnings Release |
| 2024-02-01 11:40 am | Microcap Conference - Session 2 |
| 2024-01-31 02:00 pm | Microcap Conference |
| 2024-01-17 | Gulf Coast Consortia Antimicrobial Resistance Conference |
| 2024-01-11 03:00 pm | JPMorgan Healthcare Conference |
| 2023-11-14 08:00 am | Q3 2023 Earnings Call |
| 2023-11-14 07:01 am | Q3 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Call |
| 2023-08-14 07:01 am | Q2 2023 Earnings Release |
| 2023-07-12 12:35 pm | Emerging Growth Conference |
| 2023-06-20 09:30 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-15 10:00 am | Annual General Meeting |
| 2023-05-12 08:00 am | Q1 2023 Earnings Call |
| 2023-05-12 07:01 am | Q1 2023 Earnings Release |
| 2023-04-17 06:00 am | European Clinical Microbiology and Infectious Disease Congress - Abstract No 03422 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,8 -14,2 9.68% | -12,1 -12,6 4.27% | -14,6 -12,7 -14.4% | -15,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,7 -14,1 9.73% | -12,1 -12,8 5.39% | -14,6 -12,8 -13.77% | -15,6 |
|
Net income Million USD | Released Forecast Spread | -4,60 | -12,7 -14,1 9.73% | -12,1 -12,8 5.39% | -14,6 -12,7 -14.4% | -15,6 |
|
EPS USD | Released Forecast Spread | -0,75 | -1,49 -1,69 11.83% | -1,12 -1,19 5.88% | -1,15 -1,02 -13.3% | -0,97 |
| Announcement Date | 05/04/21 | 16/03/22 | 15/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -2,63 -4,00 34.32% | -2,67 -3,38 20.96% | -3,54 -3,50 -1.19% | -3,26 -3,80 14.2% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -3,80 | -3,20 | -2,90 | -5,70 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,63 -4,00 34.32% | -2,67 -3,38 20.96% | -3,54 -3,50 -1.19% | -3,26 -3,95 17.46% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -3,80 | -3,20 | -2,90 | -5,70 | |
|
Net income Million USD | Released Forecast Spread | -2,63 -4,00 34.32% | -2,67 -3,38 20.96% | -2,62 | -3,54 -3,50 -1.19% | -3,26 -3,95 17.46% | -2,90 -4,00 27.43% | -3,45 -3,38 -1.95% | -3,11 -3,55 12.25% | -5,11 -3,35 -52.65% | -3,80 | -3,20 | -2,90 | -5,70 |
|
EPS USD | Released Forecast Spread | -0,22 -0,40 45% | -0,26 -0,33 21.21% | -0,26 | -0,32 -0,34 5.88% | -0,28 -0,35 20% | -0,25 -0,34 26.47% | -0,28 -0,29 3.45% | -0,24 -0,28 14.29% | -0,38 -0,25 -55.1% | -0,24 | -0,20 | -0,18 | -0,35 |
| Announcement Date | 16/03/22 | 10/05/22 | 12/08/22 | 10/11/22 | 15/03/23 | 12/05/23 | 11/08/23 | 13/11/23 | 15/03/24 | - | - | - | - |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Acurx Pharmaceuticals, Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 04:01 pm | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-27 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACXP Stock
- Calendar Acurx Pharmaceuticals, Inc.
